188 related articles for article (PubMed ID: 20300775)
1. PTEN mutation spectrum in breast cancers and breast hyperplasia.
Yang J; Ren Y; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T; Dai F
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1303-11. PubMed ID: 20300775
[TBL] [Abstract][Full Text] [Related]
2. NOEY2 mutations in primary breast cancers and breast hyperplasia.
Yang J; Hu A; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T
Breast; 2009 Jun; 18(3):197-203. PubMed ID: 19482475
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes.
Singh K; Scalia J; Legare R; Quddus MR; Sung CJ
Hum Pathol; 2024 Apr; 146():49-56. PubMed ID: 38608781
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression.
Kechagioglou P; Papi RM; Provatopoulou X; Kalogera E; Papadimitriou E; Grigoropoulos P; Nonni A; Zografos G; Kyriakidis DA; Gounaris A
Anticancer Res; 2014 Mar; 34(3):1387-400. PubMed ID: 24596386
[TBL] [Abstract][Full Text] [Related]
5. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.
Perren A; Weng LP; Boag AH; Ziebold U; Thakore K; Dahia PL; Komminoth P; Lees JA; Mulligan LM; Mutter GL; Eng C
Am J Pathol; 1999 Oct; 155(4):1253-60. PubMed ID: 10514407
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the PTEN gene in a human hepatic angiosarcoma.
Tate G; Suzuki T; Mitsuya T
Cancer Genet Cytogenet; 2007 Oct; 178(2):160-2. PubMed ID: 17954274
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic profiling of the PI3K/PTEN pathway in sporadic breast cancer.
Nassiri I; Faghihi M; Tavassoli M
Iran Biomed J; 2009 Apr; 13(2):79-86. PubMed ID: 19471547
[TBL] [Abstract][Full Text] [Related]
10. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
[TBL] [Abstract][Full Text] [Related]
11. PTEN expression and mutation in colorectal carcinomas.
Li XH; Zheng HC; Takahashi H; Masuda S; Yang XH; Takano Y
Oncol Rep; 2009 Oct; 22(4):757-64. PubMed ID: 19724853
[TBL] [Abstract][Full Text] [Related]
12. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression.
Feng ZZ; Chen JW; Yang ZR; Lu GZ; Cai ZG
Med Oncol; 2012 Mar; 29(1):304-10. PubMed ID: 21181309
[TBL] [Abstract][Full Text] [Related]
13. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India.
Siddiqui S; Akhter N; Deo SV; Shukla NK; Husain SA
Breast Cancer; 2016 Nov; 23(6):922-931. PubMed ID: 26754093
[TBL] [Abstract][Full Text] [Related]
14. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
[TBL] [Abstract][Full Text] [Related]
15. Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers.
Ueda K; Nishijima M; Inui H; Watatani M; Yayoi E; Okamura J; Yasutomi M; Nakamura Y; Miyoshi Y
Jpn J Cancer Res; 1998 Jan; 89(1):17-21. PubMed ID: 9510470
[TBL] [Abstract][Full Text] [Related]
16. PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer.
Guo CY; Xu XF; Wu JY; Liu SF
World J Gastroenterol; 2008 Jun; 14(24):3804-11. PubMed ID: 18609703
[TBL] [Abstract][Full Text] [Related]
17. [Expression of microRNA-21 in invasive ductal carcinoma of the breast and its association with phosphatase and tensin homolog deleted from chromosome expression and clinicopathologic features].
Huang GL; Zhang XH; Guo GL; Huang KT; Yang KY; Hu XQ
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2833-7. PubMed ID: 19080492
[TBL] [Abstract][Full Text] [Related]
18. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
[TBL] [Abstract][Full Text] [Related]
19. [Mutation and expression of tumor suppressor gene phosphatase and tensin homolog deleted in chromosome 10 in oral squamous cell carcinoma].
Li Q; Zhao JZ; Chen YN; Zhang T; Zhou L; Jin Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Nov; 44(11):660-3. PubMed ID: 20079266
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
